Autus Asset Management’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $3.14M | Sell |
|
|||||
|
2022
Q3 | $3.17M | Buy |
|
|||||
|
2022
Q2 | $2.96M | Buy |
|
|||||
|
2022
Q1 | $3.21M | Sell |
|
|||||
|
2021
Q4 | $5.94M | Sell |
|
|||||
|
2021
Q3 | $6.7M | Buy |
|
|||||
|
2021
Q2 | $7.04M | Buy |
|
|||||
|
2021
Q1 | $7.03M | Buy |
|
|||||
|
2020
Q4 | $7.27M | Sell |
|
|||||
|
2020
Q3 | $6.16M | Buy |
|
|||||
|
2020
Q2 | $6.13M | Buy |
|
|||||
|
2020
Q1 | $4.12M | Buy |
|
|||||
|
2019
Q4 | $4.96M | Buy |
|
|||||
|
2019
Q3 | $3.85M | Sell |
|
|||||
|
2019
Q2 | $4.48M | Sell |
|
|||||
|
2019
Q1 | $4.64M | Buy |
|
|||||
|
2018
Q4 | $3.27M | Sell |
|
|||||
|
2018
Q3 | $4.41M | Buy |
|
|||||
|
2018
Q2 | $4.28M | Sell |
|
|||||
|
2018
Q1 | $3.95M | Buy |
|
|||||
|
2017
Q4 | $3.67M | Buy |
|
|||||
|
2017
Q3 | $3.65M | Buy |
|
|||||
|
2017
Q2 | $3.06M | Buy |
|
|||||
|
2017
Q1 | $2.68M | Sell |
|
|||||
|
2016
Q4 | $2.37M | Buy |
|
|||||
|
2016
Q3 | $2.63M | Buy |
|
|||||
|
2016
Q2 | $2.14M | Buy |
|
|||||
|
2016
Q1 | $1.94M | Sell |
|
|||||
|
2015
Q4 | $2.67M | Sell |
|
|||||
|
2015
Q3 | $2.4M | Sell |
|
|||||
|
2015
Q2 | $3.34M | Sell |
|
|||||
|
2015
Q1 | $3.07M | Sell |
|
|||||
|
2014
Q4 | $2.58M | Buy |
|
|||||
|
2014
Q3 | $2.08M | Buy |
|
|||||
|
2014
Q2 | $2.02M | Sell |
|
|||||
|
2014
Q1 | $1.95M | Buy |
|
|||||
|
2013
Q4 | $1.53M | Buy |
|
|||||
|
2013
Q3 | $1.49M | Buy |
|
|||||
|
2013
Q2 | $1.09M | Buy |
|